In situ materials formation
Methods and apparatus of forming hydrogel systems in situ are provided using a delivery system configured to deliver two or more fluent prepolymer solutions without premature crosslinking. The delivery system comprises separate first and second lumens coupling first and second inlet ports and first and second outlet ports, respectively, and may include a balloon, flexible distal region, mixing chamber or steerable distal end. Multi-component hydrogel systems suitable for use with the inventive methods and apparatus are also described.
1. A method of embolizing a blood vessel comprising introducing an aqueous solution of a polymerizable macromer into the blood vessel and polymerizing the macromer to form a covalently crosslinked polymer that embolizes the blood vessel.
2. The method of claim 1 wherein the macromer comprises at least two functional groups chosen from the group consisting of acrylates and methacrylates.
3. The method of claim 2 comprising initiating the polymerization of the macromer by mixing the macromer with an initiator chosen from the group consisting of thermal initiators or redox initiators.
4. The method of claim 1 wherein the macromer comprises polyethylene oxide.
5. The method of claim 1 wherein the solution comprises a radiopacifying agent.
6. The method of claim 1 wherein the polymerization comprises reacting the macromer with a crosslinker that forms covalent crosslinks with the first macromer or polymerization product of the first macromer.
7. The method of claim 6 wherein at least one of the macromers comprises a succinimide or succinimidyl ester.
8. The method of claim 1 wherein the covalently crosslinked polymer is bioresorbable.
9. The method of claim 1 wherein the covalently crosslinked polymer is bioresorbable in about one week to about three weeks.
10. The method of claim 1 wherein the covalently crosslinked polymer is hydrolytically degradable in water into water soluble substances.
11. A method of treating an aneurysm comprising introducing an aqueous solution of a polymerizable macromer into the aneurysm and polymerizing the macromer to form a covalently crosslinked polymer in the aneurysm.
12. The method of claim 11 wherein the macromer comprises at least two functional groups chosen from the group consisting of acrylates and methacrylates.
13. The method of claim 11 comprising initiating the polymerization of the macromer by mixing the macromer with an initiator chosen from the group consisting of thermal initiators or redox initiators.
14. The method of claim 11 wherein the macromer comprises polyethylene oxide.
15. The method of claim 11 wherein the solution comprises a radiopacifying agent.
16. The method of claim 11 wherein the polymerization comprises reacting the macromer with a crosslinker that forms covalent crosslinks with the first macromer or polymerization product of the first macromer.
17. The method of claim 16 wherein at least one of the macromers comprises a succinimide or succinimidyl ester.
18. The method of claim 11 wherein the covalently crosslinked polymer is bioresorbable.
19. The method of claim 11 wherein the covalently crosslinked polymer is bioresorbable in about one week to about three weeks.
20. The method of claim 11 wherein the covalently crosslinked polymer is hydrolytically degradable in water into water soluble substances.
21. The method of claim 11 further comprising bridging the aneurysm with a stent or stent graft, and introducing the solution into the aneurysm and external to the stent or stent graft.